Cargando…
Determining the Anticancer Activity of Sphingosine Kinase Inhibitors Containing Heteroatoms in Their Tail Structure
Sphingosine kinase (SK) enzyme, a central player of sphingolipid rheostat, catalyzes the phosphorylation of sphingosine to the bioactive lipid mediator sphingosine 1 phosphate (S1P), which regulates cancer cell proliferation, migration, differentiation, and angiogenesis through its extracellular fiv...
Autores principales: | Shrestha, Jitendra, Kim, Seong Woong, Kim, Su-Bin, Oh, Yoon Sin, Ki, Sung Hwan, Lee, Taeho, Kim, Sang-Bum, Park, Taeuk, Baek, Dong Jae, Park, Eun-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779255/ https://www.ncbi.nlm.nih.gov/pubmed/35057052 http://dx.doi.org/10.3390/pharmaceutics14010157 |
Ejemplares similares
-
Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity
por: Kim, Su Bin, et al.
Publicado: (2020) -
Synthesis of Novel FTY720 Analogs with Anticancer Activity through PP2A Activation
por: Shrestha, Jitendra, et al.
Publicado: (2018) -
Sphingosine kinase 1 as an anticancer therapeutic target
por: Gao, Ying, et al.
Publicado: (2015) -
Heteroatom-bridged molecular belts as containers
por: Xie, Jialin, et al.
Publicado: (2020) -
Phytosphingosine induces systemic acquired resistance through activation of sphingosine kinase
por: Seo, So Yeon, et al.
Publicado: (2021)